GEN Exclusives

More »

GEN Poll

More »
Feb 24, 2014

Drugmaking in India

The FDA Commissioner recently traveled to India to express the agency’s reservations over shortcomings involving the processes used by several of India’s drug manufacturers. The visit also highlighted the challenges Washington perceives from India’s growing domestic biopharma industry. (For more on the visit, click here.)

Do you think the U.S. concern over pharmaceutical manufacturing operations in India might be more motivated by competitive issues rather than quality control problems?


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Sustainability in New Dietary Guidelines

Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?

More »